Elanco Animal Health Incorporated
US ˙ NYSE ˙ US28414H1032

Introduction

This page provides a comprehensive analysis of the known insider trading history of Kapila K Anand. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Kapila K Anand has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ELAN / Elanco Animal Health Incorporated Director 84,659
US:OHI / Omega Healthcare Investors, Inc. Director 14,676
US:US26908BAK98 / ESH Hospitality, Inc., Term Loan Director 0
US:US30227FAL40 / Extended Stay America Trust Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Kapila K Anand. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ELAN / Elanco Animal Health Incorporated - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ELAN / Elanco Animal Health Incorporated. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2022-03-01 TNC Anand Kapila K 1,000 28.4790 1,000 28.4790 28,479 17 27.4200 -1,059 -3.72
2020-03-04 ELAN Anand Kapila K 1,000 26.8600 1,000 26.8600 26,860
2018-09-24 ELAN Anand Kapila K 1,200 24.0000 1,200 24.0000 28,800

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ELAN / Elanco Animal Health Incorporated Insider Trades
Insider Sales ELAN / Elanco Animal Health Incorporated - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ELAN / Elanco Animal Health Incorporated. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ELAN / Elanco Animal Health Incorporated Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Kapila K Anand as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-12-03 2024-11-29 4 ELAN Elanco Animal Health Inc
Common Stock
A - Award 18,169 84,659 27.33
2023-12-04 2023-11-30 4 ELAN Elanco Animal Health Inc
Common Stock
A - Award 20,374 66,490 44.18
2022-12-02 2022-11-30 4 ELAN Elanco Animal Health Inc
Common Stock
A - Award 18,649 46,116 67.90
2022-03-03 2022-03-01 4 TNC Elanco Animal Health Inc
Common Stock
P - Purchase 1,000 27,467 3.78 28.48 28,479 782,233
2022-01-04 2021-12-31 4 ELAN Elanco Animal Health Inc
Deferred Stock Units
A - Award 169 1,458 13.10 28.38 4,792 41,380
2021-12-02 2021-11-30 4 ELAN Elanco Animal Health Inc
Deferred Stock Units
A - Award 167 1,289 14.85 28.74 4,792 37,053
2021-12-02 2021-11-30 4 ELAN Elanco Animal Health Inc
Common Stock
A - Award 7,307 26,467 38.14
2021-11-15 2021-11-15 4 OHI OMEGA HEALTHCARE INVESTORS INC
Common Stock
P - Purchase 1,000 14,676 7.31 28.32 28,318 415,589
2021-11-02 2021-10-29 4 ELAN Elanco Animal Health Inc
Deferred Stock Units
A - Award 112 1,123 11.03 32.88 3,667 36,908
2021-10-04 2021-09-30 4 ELAN Elanco Animal Health Inc
Deferred Stock Units
A - Award 115 1,011 12.83 31.89 3,667 32,241
2021-09-02 2021-08-31 4 ELAN Elanco Animal Health Inc
Deferred Stock Units
A - Award 110 896 13.97 33.38 3,667 29,909
2021-08-03 2021-07-30 4 ELAN Elanco Animal Health Inc
Deferred Stock Units
A - Award 101 786 14.66 36.37 3,657 28,593
2021-08-03 2021-06-30 4 ELAN Elanco Animal Health Inc
Deferred Stock Units
A - Award 106 686 18.23 34.69 3,667 23,785
2021-08-03 2021-05-28 4 ELAN Elanco Animal Health Inc
Deferred Stock Units
A - Award 102 580 21.32 35.98 3,667 20,866
2021-08-03 2021-04-30 4 ELAN Elanco Animal Health Inc
Deferred Stock Units
A - Award 116 478 31.91 31.71 3,667 15,158
2021-08-03 2021-03-31 4 ELAN Elanco Animal Health Inc
Deferred Stock Units
A - Award 125 362 52.34 29.45 3,667 10,673
2021-08-03 2021-02-26 4 ELAN Elanco Animal Health Inc
Deferred Stock Units
A - Award 112 238 88.34 32.86 3,667 7,817
2021-08-03 2021-01-29 4 ELAN Elanco Animal Health Inc
Deferred Stock Units
A - Award 126 126 29.03 3,667 3,667
2021-07-26 2021-07-22 4 OHI OMEGA HEALTHCARE INVESTORS INC
Deferred Stock Units
A - Award 1,014 7,122 16.60
2021-06-21 2021-06-16 4 NONE ESH Hospitality, Inc.
Paired Shares
D - Sale to Issuer -1,500 0 -100.00 18.75 -28,125
2021-06-21 2021-06-16 4 NONE ESH Hospitality, Inc.
Paired Shares
D - Sale to Issuer -41,001 0 -100.00 18.75 -768,769
2021-06-17 2021-06-16 4 STAY Extended Stay America, Inc.
Paired Shares
S - Sale -1,500 0 -100.00 18.75 -28,125
2021-06-17 2021-06-16 4 STAY Extended Stay America, Inc.
Paired Shares
S - Sale -41,001 0 -100.00 18.75 -768,769
2021-06-09 2021-06-07 4 OHI OMEGA HEALTHCARE INVESTORS INC
Deferred Stock Units
A - Award 6,108 6,108
2020-12-02 2020-11-30 4 ELAN Elanco Animal Health Inc
Common Stock
A - Award 5,885 19,160 44.33
2020-06-15 2020-06-11 4 OHI OMEGA HEALTHCARE INVESTORS INC
Common Stock
A - Award 4,597 13,676 50.63 32.63 150,000 446,248
2020-05-29 2020-05-28 4 STAY Extended Stay America, Inc.
Paired Shares
A - Award 10,918 41,001 36.29
2020-05-29 2020-05-28 4 NONE ESH Hospitality, Inc.
Paired Shares
A - Award 10,918 41,001 36.29
2020-03-09 2020-03-06 4 NONE ESH Hospitality, Inc.
Paired Shares
P - Purchase 1,500 1,500 9.95 14,925 14,925
2020-03-09 2020-03-06 4 STAY Extended Stay America, Inc.
Paired Shares
P - Purchase 1,500 1,500 9.95 14,925 14,925
2020-03-06 2020-03-04 4 ELAN Elanco Animal Health Inc
Common Stock
P - Purchase 1,000 13,275 8.15 26.86 26,860 356,566
2019-12-02 2019-11-29 4 ELAN Elanco Animal Health Inc
Common Stock
A - Award 6,496 12,275 112.41
2019-06-11 2019-06-07 4 OHI OMEGA HEALTHCARE INVESTORS INC
Common Stock
A - Award 4,138 9,079 83.75 36.25 150,002 329,114
2019-05-30 2019-05-30 4 NONE ESH Hospitality, Inc.
Paired Shares
A - Award 8,450 30,083 39.06
2019-05-30 2019-05-30 4 STAY Extended Stay America, Inc.
Paired Shares
A - Award 8,450 30,083 39.06
2019-04-12 2019-04-11 4 ELAN Elanco Animal Health Inc
Common Stock
A - Award 2,783 5,779 92.89
2018-12-04 2018-11-30 4 ELAN Elanco Animal Health Inc
Common Stock
A - Award 1,796 2,996 149.67
2018-09-26 2018-09-24 4 ELAN Elanco Animal Health Inc
Common Stock
P - Purchase 1,200 1,200 24.00 28,800 28,800
2018-06-11 2018-06-08 4 OHI OMEGA HEALTHCARE INVESTORS INC
Common Stock
A - Award 4,941 4,941 30.36 150,009 150,009
2018-05-17 2018-05-15 4 NONE ESH Hospitality, Inc.
Paired Shares
A - Award 7,550 21,633 53.61
2018-05-17 2018-05-15 4 STAY Extended Stay America, Inc.
Paired Shares
A - Award 7,550 21,633 53.61
2017-05-19 2017-05-17 4 STAY Extended Stay America, Inc.
Paired Shares
A - Award 8,502 14,083 152.34
2017-05-19 2017-05-17 4 NONE ESH Hospitality, Inc.
Paired Shares
A - Award 8,502 14,083 152.34
2017-05-19 3 NONE ESH Hospitality, Inc.
Paired Shares
11,162
2017-05-19 3 NONE ESH Hospitality, Inc.
Paired Shares
11,162
2016-08-05 2016-08-04 4 STAY Extended Stay America, Inc.
Paired Shares
A - Award 5,581 5,581
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)